Abstract Background/Aim: The effectiveness of using serum thyroglobulin (TG) to predict
thyroid cancer recurrence after a thyroid lobectomy is unknown. This study aimed to …

Background The role of measuring serum thyroglobulin (Tg) levels in patients who have
undergone lobectomy has not been proven. The goal of this research is to see if serum Tg …

Background: The value of serum thyroglobulin/antithyroglobulin (Tg/antithyroglobulin
antibody [ATg]) for papillary thyroid carcinoma (PTC) surveillance after lobectomy was …

Background: Low-risk patients with differentiated thyroid cancer can be treated with thyroid
lobectomy. Serial measurements of serum thyroglobulin (Tg) are recommended for …

Background: Thyroidectomy followed by administration of large activities of 131I is the
treatment of choice for differentiated thyroid carcinomas. Due to its good prognosis, some …

Abstract Background and Objectives Although there are many factors that affect
postoperative serum levels of thyroglobulin (Tg), such levels have been previously used to …

Background The use of thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) for detecting
disease recurrence is well validated following total thyroidectomy and radioiodine ablation …

Abstract Background Thyroglobulin (Tg) is a marker of tumor recurrence during thyroid
cancer follow-up. While helpful in the postoperative setting, the clinical significance of …

Background: Thyroglobulin is an excellent biological marker of persistent or recurrent thyroid
cancer during long-term follow-up. Most studies investigated its diagnostic value but not its …

Purpose Serum thyroglobulin (TG) is used to monitor for recurrence or progression of
differentiated thyroid cancer (DTC). The role of preoperative TG measurement is more …